🇺🇸 FDA
Patent

US 6713507

Ether compounds and compositions for cholesterol management and related uses

expired A61KA61K31/275A61P

Quick answer

US patent 6713507 (Ether compounds and compositions for cholesterol management and related uses) held by Esperion Therapeutics, Inc. expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/275, A61P, A61P1/18, A61P13/12